BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Precision BioSciences Announces Presentation at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

  February 18, 2026

   · 

  5 min read
• Press Releases

  Charles River Laboratories Announces Executive Appointments

  February 18, 2026

   · 

  8 min read
• Press Releases

  Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

  February 18, 2026

   · 

  1 min read
• Press Releases

  NeoGenomics to Participate in Upcoming March 2026 Investor Conferences

  February 18, 2026

   · 

  1 min read
• Press Releases

  Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors

  February 18, 2026

   · 

  7 min read
• Press Releases

  NervGen Pharma to Participate at Upcoming Investor Conferences - February 18, 2026

  February 18, 2026

   · 

  5 min read
• Press Releases

  Medicenna Therapeutics Announces Participation in Upcoming Conferences

  February 18, 2026

   · 

  4 min read
• Press Releases

  Medline announces participation in the Barclays 28th Annual Global Healthcare Conference

  February 18, 2026

   · 

  1 min read
• Press Releases

  RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer

  February 18, 2026

   · 

  26 min read
• Press Releases

  Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)

  February 18, 2026

   · 

  10 min read